Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$42.57 USD

42.57
740,451

-0.06 (-0.14%)

Updated Sep 27, 2024 04:00 PM ET

After-Market: $42.57 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (164 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Veeva (VEEV) Beats on Q4 Earnings, Narrows '23 Revenue View

Veeva Systems' (VEEV) fiscal Q4 results reflect impressive performances by both of its segments.

Quidel (QDEL) Rallies 17.4% Since Posting Q4 Earnings Beat

Quidel (QDEL) stock rallies on better-than-expected fourth-quarter performance and strong diagnostics portfolio.

Here's Why You Should Invest in AmerisourceBergen (ABC) Stock

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment.

Masimo's (MASI) SedLine Receives FDA's Pediatric Indication

The latest FDA clearance for Masimo's (MASI) SedLine is likely to improve brain function monitoring in pediatric patients.

Insulet (PODD) Product Volume Up, COVID-Led Softness Persists

Insulet's (PODD) drug delivery revenues surge led by increased production volumes, driven by higher-than-expected demand from its partner.

Henry Schein (HSIC) Expands Data Analytics to Private Practices

Henry Schein's (HSIC) introduction of Jarvis Analytics for Private Practices offers practice owners a simple, powerful tool to help improve practice success through data-driven decisions.

Alcon (ALC) Surgical Arm Expands, International Growth Slows

In Surgical, Alcon (ALC) remains the market leader in presbyopia correcting IOLs on the strength of both PanOptix and Vivity.

Medtronic's (MDT) NuVent Balloon to Strengthen ENT Business

Medtronic's (MDT) Nuvent balloons are one-time use devices featuring a flexible balloon section that allows customized placement based on patient anatomy.

Inogen (INGN) Stock Surges 16.5% Despite Q4 Earnings Miss

Inogen's (INGN) fourth-quarter results benefit from higher revenues across the majority of its geographical segments.

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health (CVS) on continued growth in its consumer-centric digital solutions.

Zacks.com featured highlights include: ConocoPhillips, Tyson Foods, Inc., AMN Healthcare Services, Inc., WESCO International, Inc. and Capri Holdings Ltd

ConocoPhillips, Tyson Foods, Inc., AMN Healthcare Services, Inc., WESCO International, Inc. and Capri Holdings Ltd are highlighted in this Screen of the Week article.

Looking for a Growth Stock? 3 Reasons Why AMN Healthcare (AMN) is a Solid Choice

AMN Healthcare (AMN) is well positioned to outperform the market, as it exhibits above-average growth in financials.

OPKO Health's (OPK) Q4 Earnings Miss Estimates, Revenues Top

OPKO Health's (OPK) fourth-quarter results benefit from continued strength in its Pharmaceuticals segment.

Merit Medical's (MMSI) Q4 Earnings, Revenues Top Estimates

Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in both its segments, and from majority of the product categories within its Cardiovascular unit.

Here's Why You Should Invest In Henry Schein (HSIC) Now

Investors are optimistic about Henry Schein's (HSIC) favorable dental business trends and bullish fourth-quarter 2021 performance.

Thermo Fisher (TMO) Extends Collaboration With Moderna

Thermo Fisher (TMO) continues to be a trusted partner of Moderna, bringing a wide range of products and services enabling Moderna to deliver innovative medicines at an extraordinary speed and scale.

Nilanjan Choudhury headshot

Use Relative Price Strength to Survive the Market Turmoil

ConocoPhillips (COP), Tyson Foods (TSN), AMN Healthcare (AMN), WESCO International (WCC) and Capri Holdings (CPRI) are five stocks with explosive relative price strength.

Thermo Fisher (TMO) COVID Test Sales Grow, FX Woes Persist

Thermo Fisher's (TMO) strong pandemic response stance enables it to accelerate its growth strategy, and bump up investments, which encourages it to raise the 2022 core organic growth guidance.

Debanjana Dey headshot

Allscripts' (MDRX) Q4 Earnings Beat Estimates, Margins Up

Allscripts' (MDRX) robust Q4 results demonstrate strength in both segments.

Nevro's (NVRO) Q4 Earnings in Line, Revenues Beat Estimates

Nevro's (NVRO) worldwide revenues fall on a year-over-year basis in Q4 due to soft geographical performances.

Earnings Estimates Rising for AMN Healthcare (AMN): Will It Gain?

AMN Healthcare (AMN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Avanos Medical (AVNS) Q4 Earnings, Revenues Top Estimates

Avanos Medical's (AVNS) fourth-quarter 2021 results gain from strength in the chronic care segment.

AMN Healthcare Services and The Gap have been highlighted as Zacks Bull and Bear of the Day

AMN Healthcare Services and The Gap have been highlighted as Zacks Bull and Bear of the Day.

Tracey Ryniec headshot

Bull of the Day: AMN Healthcare (AMN)

Healthcare solutions is red-hot in 2022.